1. Home
  2. NKX vs PHAR Comparison

NKX vs PHAR Comparison

Compare NKX & PHAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nuveen California AMT-Free Quality Municipal Income Fund

NKX

Nuveen California AMT-Free Quality Municipal Income Fund

N/A

Current Price

$11.46

Market Cap

640.3M

Sector

Finance

ML Signal

N/A

Logo Pharming Group N.V.

PHAR

Pharming Group N.V.

N/A

Current Price

$10.78

Market Cap

793.4M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
NKX
PHAR
Founded
2002
1988
Country
United States
Netherlands
Employees
N/A
N/A
Industry
Finance/Investors Services
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
640.3M
793.4M
IPO Year
2002
2020

Fundamental Metrics

Financial Performance
Metric
NKX
PHAR
Price
$11.46
$10.78
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$38.33
AVG Volume (30 Days)
162.5K
15.3K
Earning Date
01-01-0001
05-07-2026
Dividend Yield
4.37%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$10.04
Revenue Next Year
N/A
$2.51
P/E Ratio
N/A
$3,041.22
Revenue Growth
N/A
N/A
52 Week Low
$11.60
$9.62
52 Week High
$13.20
$21.34

Technical Indicators

Market Signals
Indicator
NKX
PHAR
Relative Strength Index (RSI) 19.53 41.13
Support Level N/A $9.62
Resistance Level $12.49 $13.51
Average True Range (ATR) 0.11 0.36
MACD -0.06 -0.05
Stochastic Oscillator 10.87 19.09

Price Performance

Historical Comparison
NKX
PHAR

About NKX Nuveen California AMT-Free Quality Municipal Income Fund

Nuveen California AMT-Free Quality Municipal Income Fund is a closed-end fixed income mutual fund. The Fund's primary investment objective is current income exempt from both regular federal income taxes and Arizona individual income taxes and to enhance portfolio value relative to the municipal bond market by investing in tax-exempt municipal bonds that the Fund's investment adviser believes are underrated or undervalued or that represent municipal market sectors that are undervalued. It invests across sectors such as healthcare, utilities, transportation, and housing.

About PHAR Pharming Group N.V.

Pharming Group is a biotechnology company focused on developing and commercializing therapies for rare and ultra-rare diseases, particularly immunological and genetic conditions with high unmet need. It operates as an integrated company with capabilities across clinical development, manufacturing, regulatory affairs, and commercialization, supported by scientific and operational expertise. It leverages its efficient infrastructure to expand its pipeline and improve patient access to treatment. The Company operates in the United States, Europe, and the rest of the world, with the United States contributing the majority of its revenue.

Share on Social Networks: